HBM Holdings Limited (HKG:2142)
Hong Kong · Delayed Price · Currency is HKD 13.44
+0.08 (0.60%)
At close: Dec 12, 2025
HBM Holdings Market Cap
HBM Holdings has a market cap or net worth of 11.69 billion as of December 12, 2025. Its market cap has increased by 1,145.51% in one year.
Market Cap
11.69B
Enterprise Value
9.68B
Revenue
908.35M
Ranking
n/a
PE Ratio
18.59
Stock Price
13.44
Market Cap Chart
Since December 10, 2020, HBM Holdings's market cap has increased from 8.46B to 11.69B, an increase of 38.09%. That is a compound annual growth rate of 6.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 11.62B | 752.55% |
| Dec 31, 2024 | 1.36B | -3.91% |
| Dec 29, 2023 | 1.42B | -32.16% |
| Dec 30, 2022 | 2.09B | -63.14% |
| Dec 31, 2021 | 5.67B | -30.06% |
| Dec 31, 2020 | 8.11B | -4.17% |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 277.87B |
| Hansoh Pharmaceutical Group Company | 262.50B |
| JD Health International | 184.89B |
| Innovent Biologics | 143.36B |
| WuXi Biologics | 138.21B |
| Sino Biopharmaceutical | 120.31B |
| Akeso | 108.14B |
| Sichuan Kelun-Biotech Biopharmaceutical | 97.38B |